PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Clinical trial NCT03970538 · UNKNOWN

Trial details

NCT number: NCT03970538
Sponsor: LimFlow, Inc.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Critical Limb Ischemia Critical Lower Limb Ischemia Peripheral Artery Disease Peripheral Arterial Disease Chronic Limb-Threatening Ischemia Arterial Occlusive Diseases Arterial Occlusion Arterial Disease Peripheral Artery Occlusion Peripheral Vascular Disease Peripheral Ischemia Vascular Diseases

Start date: 2019-12-06
Primary completion: 2022-09-09
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.